BRIEF-GSK says HIV drug Triumeq gets EU marketing approval
September 03, 2014 at 08:28 AM EDT
* ViiV Healthcare receives EU marketing authorisation for Triumeq, a new once-daily single-pill regimen for treatment of HIV Source text for Eikon: Further company coverage: